-
Costs of Type 2 Diabetes Mellitus and Obesity in Colombian Caribbean Poor Population: A Top-Down Approach from a Cardiovascular Risk Cohort, 2020-2022
Mar 10, 2025, 14:00 PM -
Association Between Initiation of ENDS and Cigarette Smoking Reduction: A Causal Time Zero Approach to the PATH Study
Mar 10, 2025, 14:00 PM -
Does Our Instrument Include the Right Response Options? Empirical Evidence to Evaluate Floor and Ceiling Effects for Multi-Item Ordinal Instruments
Mar 10, 2025, 14:00 PM -
Healthcare Costs Associated With Adverse Events During Treatment Episodes for Pediatric Attention-Deficit/Hyperactivity Disorder
Mar 10, 2025, 14:00 PM -
The Costs Associated with Healthcare Resource Use and Work Productivity for Care Partners of Multiple Myeloma Patients in the United States and Europe
Mar 10, 2025, 14:00 PM -
Landscape Review of Patient Engagement in the Health Technology Assessment (HTA) Process in Latin America
Mar 10, 2025, 14:00 PM -
Comparison of Machine Learning Models To Predict US Adolescent Mentalhealth Trends
Mar 10, 2025, 14:00 PM -
A Return On Investment Evaluation Of An Antibiotic Audit And Feedback Program Among Family Physicians
Mar 10, 2025, 14:00 PM -
Can We Move Beyond a Best Guess? The Feasibility of Transportability Analysis to Estimate the Effect of GLP-1 Inhibitors in the Canadian Population
Mar 10, 2025, 14:00 PM -
Use of Diaries to Capture Patient-Reported Outcomes in FDA New Drug Approvals (2019-2023)
Mar 10, 2025, 14:00 PM -
Return on Investment and Waste Considerations for the Implementation of Rechargeable Batteries in Video Laryngoscopes
Mar 10, 2025, 14:00 PM -
Spillover Effects of Medical Innovations: A Generic and Scalable Approach to Measure the Societal Value of Avoided Informal Care Time
Mar 10, 2025, 14:00 PM -
Trends in the Prescribing and Dispensing of GLP-1 Anti-Obesity Medications Among U.S. Adults with Cardiovascular Disease and Overweight or Obesity, 2021-2024
Mar 10, 2025, 14:00 PM -
Drivers of High ICERs in SMC Appraisals
Mar 10, 2025, 14:00 PM -
Real-World Unmet Needs in Patients With HER2-Negative Advanced Gastric, Gastro-Esophageal or Esophageal Adenocarcinoma Receiving First-Line Treatment Globally
Mar 10, 2025, 14:00 PM -
A Case-Study on the Implementation of the Population Health Agreement for Inclisiran in England
Mar 10, 2025, 14:00 PM -
Content Validation of the NEI-VFQ-25 With Patients With Subfoveal and Non-subfoveal Geographic Atrophy: A Qualitative Study
Mar 10, 2025, 14:00 PM -
Hypophosphatasia (HPP) Patient & Caregiver Disease Burden, Quality of Life & Treatment Experience: A Mixed Methods Study Concept
Mar 10, 2025, 14:00 PM -
Prostate Cancer Specialist Nursing Program: A Social Return on Investment
Mar 10, 2025, 14:00 PM -
Evaluating the National and Regional Prevalence and Incidence Rates of Hepatitis Delta Virus Among Patients With Hepatitis B Virus Infection in Italy
Mar 10, 2025, 14:00 PM
